SEC
|
Wilkinson Peter J
|
SVP, Chief Accounting Officer
|
|
-1.4K
|
$210.71
|
-$291.62K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+6.7K
|
$222.56
|
+$1.49M
|
|
SEC
|
Kirchgraber Paul R
|
CEO, Covance Drug Development
|
|
+1.1K
|
$222.56
|
+$248.15K
|
|
SEC
|
Schechter Adam H
|
President & CEO
|
|
+1.1K
|
$222.56
|
+$247.93K
|
|
SEC
|
Caveney Brian J
|
EVP, President of Diagnostics
|
|
+44
|
$231.20
|
+$10.25K
|
|
SEC
|
Wilkinson Peter J
|
SVP, Chief Accounting Officer
|
|
-1.8K
|
$232.92
|
-$415.06K
|
|
SEC
|
Caveney Brian J
|
EVP, President of Diagnostics
|
|
+42
|
$242.19
|
+$10.17K
|
|
SEC
|
Schroeder Mark S
|
EVP, President-Diagnostics Lab
|
|
-2.4K
|
$277.11
|
-$652.87K
|
|
SEC
|
van der Vaart Sandra D
|
EVP, Chief Legal Officer
|
|
-2.4K
|
$277.11
|
-$678.64K
|
|
SEC
|
BERBERIAN LANCE
|
EVP, CIO & CTO
|
|
+3K
|
$85.05
|
+$250.90K
|
|
SEC
|
Caveney Brian J
|
EVP, President of Diagnostics
|
|
+2.4K
|
$84.99
|
+$200.41K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+7.9K
|
$85.05
|
+$668.32K
|
|
SEC
|
Kirchgraber Paul R
|
CEO, Covance Drug Development
|
|
+2.1K
|
$85.07
|
+$175.16K
|
|
SEC
|
Schroeder Mark S
|
EVP, President-Diagnostics Lab
|
|
+2.4K
|
$85.06
|
+$200.40K
|
|
SEC
|
van der Vaart Sandra D
|
EVP, Chief Legal Officer
|
|
+2.4K
|
$82.11
|
+$201.09K
|
|
SEC
|
Wilkinson Peter J
|
SVP, Chief Accounting Officer
|
|
+1.9K
|
$67.68
|
+$129.07K
|
|
SEC
|
Williams R Sanders
|
N/A
|
|
-572
|
$272.98
|
-$156.14K
|
|
SEC
|
Summy Amy B.
|
EVP, Chief Marketing Officer
|
|
-249
|
$262.21
|
-$65.29K
|
|
SEC
|
NEUPERT PETER M
|
N/A
|
|
+3.5K
|
$263.66
|
+$922.81K
|
|
SEC
|
Schroeder Mark S
|
EVP, President-Diagnostics Lab
|
|
-207
|
$273.98
|
-$56.71K
|
|
SEC
|
van der Vaart Sandra D
|
EVP, Chief Legal Officer
|
|
-207
|
$273.98
|
-$56.71K
|
|
SEC
|
BERBERIAN LANCE
|
EVP, CIO & CTO
|
|
+1.9K
|
$272.68
|
+$520.55K
|
|
SEC
|
Caveney Brian J
|
EVP, President of Diagnostics
|
|
+1.9K
|
$272.68
|
+$507.18K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+663
|
$272.68
|
+$180.79K
|
|
SEC
|
Kirchgraber Paul R
|
CEO, Covance Drug Development
|
|
+209
|
$272.68
|
+$56.99K
|
|
SEC
|
Schroeder Mark S
|
EVP, President-Diagnostics Lab
|
|
+207
|
$272.68
|
+$56.44K
|
|
SEC
|
van der Vaart Sandra D
|
EVP, Chief Legal Officer
|
|
+207
|
$272.68
|
+$56.44K
|
|
SEC
|
Wilkinson Peter J
|
SVP, Chief Accounting Officer
|
|
+606
|
$272.68
|
+$165.24K
|
|
SEC
|
Schroeder Mark S
|
EVP, President-Diagnostics Lab
|
|
-204
|
$277.38
|
-$56.59K
|
|
SEC
|
van der Vaart Sandra D
|
EVP, Chief Legal Officer
|
|
-218
|
$277.38
|
-$60.47K
|
|
SEC
|
Schroeder Mark S
|
EVP, President-Diagnostics Lab
|
|
+161
|
$272.40
|
+$43.86K
|
|
SEC
|
BELINGARD JEAN-LUC
|
N/A
|
|
+693
|
$273.18
|
+$189.31K
|
|
SEC
|
BERBERIAN LANCE
|
EVP, CIO & CTO
|
|
+193
|
$273.18
|
+$52.72K
|
|
SEC
|
Caveney Brian J
|
EVP, President of Diagnostics
|
|
+296
|
$273.18
|
+$80.86K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+530
|
$273.18
|
+$144.79K
|
|
SEC
|
Kirchgraber Paul R
|
CEO, Covance Drug Development
|
|
+299
|
$273.18
|
+$81.68K
|
|
SEC
|
Schechter Adam H
|
President & CEO
|
|
+2K
|
$273.18
|
+$538.16K
|
|
SEC
|
Seltz Judith C
|
EVP, CHRO
|
|
+144
|
$273.18
|
+$39.34K
|
|
SEC
|
Summy Amy B.
|
EVP, Chief Marketing Officer
|
|
+143
|
$273.18
|
+$39.06K
|
|
SEC
|
Wilkinson Peter J
|
SVP, Chief Accounting Officer
|
|
+75
|
$273.18
|
+$20.49K
|
|
SEC
|
Gilliland Dwight Gary
|
N/A
|
|
-500
|
$302.26
|
-$151.13K
|
|
SEC
|
Caveney Brian J
|
EVP, President of Diagnostics
|
|
+1.1K
|
$274.84
|
+$305.35K
|
|
SEC
|
Schroeder Mark S
|
EVP, President-Diagnostics Lab
|
|
+1.1K
|
$274.84
|
+$305.35K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+5K
|
$288.78
|
+$1.44M
|
|
SEC
|
Kirchgraber Paul R
|
CEO, Covance Drug Development
|
|
+1.1K
|
$288.78
|
+$320.26K
|
|
SEC
|
Schechter Adam H
|
President & CEO
|
|
+1.1K
|
$288.78
|
+$323.72K
|
|
SEC
|
Wilkinson Peter J
|
SVP, Chief Accounting Officer
|
|
+35
|
$297.61
|
+$10.42K
|
|
SEC
|
Kirchgraber Paul R
|
CEO, Covance Drug Development
|
|
-2.5K
|
$276.55
|
-$691.38K
|
|
SEC
|
Kirchgraber Paul R
|
CEO, Covance Drug Development
|
|
+558
|
$252.67
|
+$140.99K
|
|
SEC
|
Schroeder Mark S
|
EVP, President-Diagnostics Lab
|
|
-667
|
$251.88
|
-$168.00K
|
|
SEC
|
van der Vaart Sandra D
|
EVP, Chief Legal Officer
|
|
-812
|
$251.88
|
-$204.53K
|
|
SEC
|
Wilkinson Peter J
|
SVP, Chief Accounting Officer
|
|
+453
|
$202.80
|
+$91.87K
|
|
SEC
|
Schroeder Mark S
|
EVP, President-Diagnostics Lab
|
|
+187
|
$237.58
|
+$44.43K
|
|
SEC
|
van der Vaart Sandra D
|
EVP, Chief Legal Officer
|
|
+207
|
$237.29
|
+$49.12K
|
|
SEC
|
BERBERIAN LANCE
|
EVP, CIO & CTO
|
|
+2.1K
|
$238.26
|
+$492.48K
|
|
SEC
|
Caveney Brian J
|
EVP, President of Diagnostics
|
|
+2K
|
$238.26
|
+$480.33K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+1.2K
|
$238.26
|
+$287.82K
|
|
SEC
|
Kirchgraber Paul R
|
CEO, Covance Drug Development
|
|
+401
|
$238.26
|
+$95.54K
|
|
SEC
|
Schroeder Mark S
|
EVP, President-Diagnostics Lab
|
|
+203
|
$224.96
|
+$45.67K
|
|
SEC
|
van der Vaart Sandra D
|
EVP, Chief Legal Officer
|
|
+108
|
$224.96
|
+$24.30K
|
|
SEC
|
BELINGARD JEAN-LUC
|
N/A
|
|
+887
|
$223.78
|
+$198.49K
|
|
SEC
|
BERBERIAN LANCE
|
EVP, CIO & CTO
|
|
+242
|
$223.78
|
+$54.15K
|
|
SEC
|
Caveney Brian J
|
EVP, President of Diagnostics
|
|
+370
|
$223.78
|
+$82.80K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+664
|
$223.78
|
+$148.59K
|
|
SEC
|
Kirchgraber Paul R
|
CEO, Covance Drug Development
|
|
+373
|
$223.78
|
+$83.47K
|
|
SEC
|
Schechter Adam H
|
President & CEO
|
|
+2.5K
|
$223.78
|
+$554.53K
|
|
SEC
|
Seltz Judith C
|
EVP, CHRO
|
|
+184
|
$223.78
|
+$41.18K
|
|
SEC
|
Summy Amy B.
|
EVP, Chief Marketing Officer
|
|
+172
|
$223.78
|
+$38.49K
|
|
SEC
|
Wilkinson Peter J
|
SVP, Chief Accounting Officer
|
|
+97
|
$223.78
|
+$21.71K
|
|
SEC
|
Williams R Sanders
|
N/A
|
|
+151
|
$52.28
|
+$7.89K
|
|
SEC
|
Schroeder Mark S
|
EVP, President-Diagnostics Lab
|
|
-588
|
$214.59
|
-$126.18K
|
|
SEC
|
Caveney Brian J
|
EVP, President of Diagnostics
|
|
+1.1K
|
$214.42
|
+$241.01K
|
|
SEC
|
Schroeder Mark S
|
EVP, President-Diagnostics Lab
|
|
+1.2K
|
$214.42
|
+$251.94K
|
|
SEC
|
Kirchgraber Paul R
|
CEO, Covance Drug Development
|
|
-1.5K
|
$214.14
|
-$321.21K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+5K
|
$207.23
|
+$1.03M
|
|
SEC
|
Kirchgraber Paul R
|
CEO, Covance Drug Development
|
|
+1.1K
|
$207.23
|
+$230.23K
|
|
SEC
|
Schechter Adam H
|
President & CEO
|
|
+1.1K
|
$207.23
|
+$232.30K
|
|
SEC
|
Caveney Brian J
|
EVP, President of Diagnostics
|
|
+681
|
$180.99
|
+$123.25K
|
|
SEC
|
van der Vaart Sandra D
|
EVP, Chief Legal Officer
|
|
-435
|
$170.00
|
-$73.95K
|
|
SEC
|
van der Vaart Sandra D
|
EVP, Chief Legal Officer
|
|
-872
|
$160.33
|
-$139.81K
|
|
SEC
|
KING DAVID P
|
N/A
|
|
-31K
|
$160.00
|
-$5.00M
|
|
SEC
|
Kirchgraber Paul R
|
CEO, Covance Drug Development
|
|
+638
|
$30.50
|
+$19.46K
|
|
SEC
|
BERBERIAN LANCE
|
EVP, CIO & CTO
|
|
+2.2K
|
$40.12
|
+$87.66K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+7.2K
|
$40.76
|
+$291.76K
|
|
SEC
|
KING DAVID P
|
N/A
|
|
+30K
|
$40.76
|
+$1.24M
|
|
SEC
|
Kirchgraber Paul R
|
CEO, Covance Drug Development
|
|
+2.4K
|
$30.30
|
+$72.36K
|
|
SEC
|
Schroeder Mark S
|
EVP, President-Diagnostics Lab
|
|
+2.7K
|
$30.23
|
+$82.44K
|
|
SEC
|
van der Vaart Sandra D
|
EVP, Chief Legal Officer
|
|
+2.6K
|
$30.23
|
+$79.05K
|
|
SEC
|
Seltz Judith C
|
EVP, CHRO
|
|
+580
|
$171.31
|
+$99.36K
|
|
SEC
|
Wilkinson Peter J
|
SVP, Chief Accounting Officer
|
|
-297
|
$189.65
|
-$56.33K
|
|
SEC
|
BELINGARD JEAN-LUC
|
N/A
|
|
-23K
|
$177.97
|
-$4.16M
|
|
SEC
|
Schroeder Mark S
|
EVP, President-Diagnostics Lab
|
|
+186
|
$188.07
|
+$34.98K
|
|
SEC
|
van der Vaart Sandra D
|
SVP, Global General Counsel
|
|
+207
|
$188.07
|
+$38.93K
|
|
SEC
|
BELINGARD JEAN-LUC
|
N/A
|
|
+1.1K
|
$187.51
|
+$207.01K
|
|
SEC
|
BERBERIAN LANCE
|
SVP, Chief Information Officer
|
|
+2.1K
|
$187.51
|
+$387.58K
|
|
SEC
|
Caveney Brian J
|
EVP, President of Diagnostics
|
|
+2K
|
$187.51
|
+$375.58K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+1.2K
|
$187.51
|
+$226.51K
|
|
SEC
|
KING DAVID P
|
N/A
|
|
+4.5K
|
$187.51
|
+$837.98K
|
|
SEC
|
Kirchgraber Paul R
|
CEO, Covance Drug Development
|
|
+420
|
$187.51
|
+$78.75K
|
|
SEC
|
Wilkinson Peter J
|
SVP, Chief Accounting Officer
|
|
+594
|
$187.51
|
+$111.38K
|
|
SEC
|
Schroeder Mark S
|
EVP, President-Diagnostics Lab
|
|
+107
|
$182.14
|
+$19.49K
|
|
SEC
|
van der Vaart Sandra D
|
SVP, Global General Counsel
|
|
+133
|
$182.14
|
+$24.22K
|
|
SEC
|
BERBERIAN LANCE
|
SVP, Chief Information Officer
|
|
+194
|
$182.33
|
+$35.37K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+699
|
$182.33
|
+$127.45K
|
|
SEC
|
KING DAVID P
|
N/A
|
|
+3K
|
$182.33
|
+$541.16K
|
|
SEC
|
Kirchgraber Paul R
|
CEO, Covance Drug Development
|
|
+234
|
$182.33
|
+$42.67K
|
|
SEC
|
BELINGARD JEAN-LUC
|
N/A
|
|
+2.9K
|
$171.82
|
+$505.84K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-30K
|
$165.40
|
-$4.99M
|
|
SEC
|
BERBERIAN LANCE
|
SVP, Chief Information Officer
|
|
-5.9K
|
$169.80
|
-$1.00M
|
|
SEC
|
Williams R Sanders
|
N/A
|
|
-500
|
$162.91
|
-$81.46K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
-5.6K
|
$176.75
|
-$983.26K
|
|
SEC
|
van der Vaart Sandra D
|
SVP, Global General Counsel
|
|
-2.3K
|
$176.75
|
-$411.47K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
-10K
|
$167.40
|
-$1.67M
|
|
SEC
|
Williams R Sanders
|
N/A
|
|
-500
|
$162.20
|
-$81.10K
|
|
SEC
|
Uthgenannt Lisa J
|
Chief Human Resources Officer
|
|
-4K
|
$164.00
|
-$656.00K
|
|
SEC
|
Ratliff John D
|
CEO, Covance Drug Development
|
|
+1.3K
|
$156.68
|
+$209.95K
|
|
SEC
|
BERBERIAN LANCE
|
SVP, Chief Information Officer
|
|
+3.2K
|
$45.29
|
+$146.88K
|
|
SEC
|
Dodson Edward T
|
Principal Accounting Officer
|
|
+3.8K
|
$37.68
|
+$141.34K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+12K
|
$47.82
|
+$592.35K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
+51K
|
$47.82
|
+$2.44M
|
|
SEC
|
Uthgenannt Lisa J
|
Chief Human Resources Officer
|
|
+4.1K
|
$47.16
|
+$195.67K
|
|
SEC
|
van der Vaart Sandra D
|
SVP, Global General Counsel
|
|
+3.7K
|
$37.72
|
+$141.37K
|
|
SEC
|
BELINGARD JEAN-LUC
|
N/A
|
|
+934
|
$105.81
|
+$98.83K
|
|
SEC
|
BERBERIAN LANCE
|
SVP, Chief Information Officer
|
|
+163
|
$146.59
|
+$23.89K
|
|
SEC
|
Caveney Brian J
|
SVP, Chief Medical Officer
|
|
+151
|
$146.59
|
+$22.14K
|
|
SEC
|
Dodson Edward T
|
Principal Accounting Officer
|
|
+142
|
$146.59
|
+$20.82K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
+169
|
$146.59
|
+$24.77K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+548
|
$146.59
|
+$80.33K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
+1.9K
|
$146.59
|
+$284.68K
|
|
SEC
|
Ratliff John D
|
CEO, Covance Drug Development
|
|
+809
|
$146.59
|
+$118.59K
|
|
SEC
|
Uthgenannt Lisa J
|
Chief Human Resources Officer
|
|
+153
|
$146.59
|
+$22.43K
|
|
SEC
|
BERBERIAN LANCE
|
SVP, Chief Information Officer
|
|
+2.5K
|
$144.29
|
+$354.95K
|
|
SEC
|
Dodson Edward T
|
Principal Accounting Officer
|
|
+326
|
$144.29
|
+$47.04K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
+377
|
$144.29
|
+$54.40K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+3.4K
|
$144.29
|
+$494.63K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
+4.6K
|
$144.29
|
+$658.54K
|
|
SEC
|
Ratliff John D
|
CEO, Covance Drug Development
|
|
+4.1K
|
$144.29
|
+$595.48K
|
|
SEC
|
Uthgenannt Lisa J
|
Chief Human Resources Officer
|
|
+364
|
$144.29
|
+$52.52K
|
|
SEC
|
BERBERIAN LANCE
|
SVP, Chief Information Officer
|
|
+193
|
$147.46
|
+$28.46K
|
|
SEC
|
Dodson Edward T
|
Principal Accounting Officer
|
|
+179
|
$147.46
|
+$26.40K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
+215
|
$147.46
|
+$31.70K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+696
|
$147.46
|
+$102.63K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
+3K
|
$147.46
|
+$437.37K
|
|
SEC
|
Ratliff John D
|
CEO, Covance Drug Development
|
|
+1.3K
|
$147.46
|
+$192.73K
|
|
SEC
|
Uthgenannt Lisa J
|
Chief Human Resources Officer
|
|
+179
|
$147.46
|
+$26.40K
|
|
SEC
|
Williams R Sanders
|
N/A
|
|
-350
|
$162.14
|
-$56.75K
|
|
SEC
|
Gary M. Huff
|
CEO, LabCorp Diagnostics
|
|
+84
|
$169.15
|
+$14.21K
|
|
SEC
|
Uthgenannt Lisa J
|
Chief Human Resources Officer
|
|
-4.5K
|
$182.10
|
-$819.45K
|
|
SEC
|
BERBERIAN LANCE
|
SVP, Chief Information Officer
|
|
-5.5K
|
$182.30
|
-$1.00M
|
|
SEC
|
Gilliland Dwight Gary
|
N/A
|
|
-1.3K
|
$181.29
|
-$228.97K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
-10K
|
$181.21
|
-$1.81M
|
|
SEC
|
Gary M. Huff
|
CEO, LabCorp Diagnostics
|
|
-1.6K
|
$182.50
|
-$293.83K
|
|
SEC
|
Gary M. Huff
|
CEO, LabCorp Diagnostics
|
|
+2.1K
|
$163.84
|
+$348.00K
|
|
SEC
|
BERBERIAN LANCE
|
SVP, Chief Information Officer
|
|
+2.7K
|
$49.20
|
+$134.37K
|
|
SEC
|
Dodson Edward T
|
Principal Accounting Officer
|
|
+3.3K
|
$40.11
|
+$130.44K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
+3.4K
|
$44.93
|
+$154.69K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+11K
|
$50.16
|
+$543.58K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
+40K
|
$50.16
|
+$2.03M
|
|
SEC
|
Uthgenannt Lisa J
|
Chief Human Resources Officer
|
|
+3.7K
|
$49.08
|
+$179.88K
|
|
SEC
|
BERBERIAN LANCE
|
SVP, Chief Information Officer
|
|
+280
|
$175.61
|
+$49.17K
|
|
SEC
|
Dodson Edward T
|
Principal Accounting Officer
|
|
+289
|
$175.61
|
+$50.75K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
+335
|
$175.61
|
+$58.83K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+895
|
$175.61
|
+$157.17K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
+3.3K
|
$175.61
|
+$587.42K
|
|
SEC
|
Uthgenannt Lisa J
|
Chief Human Resources Officer
|
|
+353
|
$175.61
|
+$61.99K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
-8.4K
|
$167.36
|
-$1.41M
|
|
SEC
|
BERBERIAN LANCE
|
SVP, Chief Information Officer
|
|
+2.4K
|
$168.08
|
+$411.63K
|
|
SEC
|
Dodson Edward T
|
Principal Accounting Officer
|
|
+283
|
$168.08
|
+$47.57K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
+376
|
$168.08
|
+$63.20K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+3.4K
|
$168.08
|
+$573.99K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
+4.4K
|
$168.08
|
+$740.39K
|
|
SEC
|
Ratliff John D
|
CEO, Covance Drug Development
|
|
+4K
|
$168.08
|
+$666.94K
|
|
SEC
|
Uthgenannt Lisa J
|
Chief Human Resources Officer
|
|
+400
|
$168.08
|
+$67.23K
|
|
SEC
|
BELINGARD JEAN-LUC
|
N/A
|
|
+1.1K
|
$169.66
|
+$192.73K
|
|
SEC
|
BERBERIAN LANCE
|
SVP, Chief Information Officer
|
|
+191
|
$169.66
|
+$32.41K
|
|
SEC
|
Dodson Edward T
|
Principal Accounting Officer
|
|
+154
|
$169.66
|
+$26.13K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
+214
|
$169.66
|
+$36.31K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+694
|
$169.66
|
+$117.74K
|
|
SEC
|
Gary M. Huff
|
CEO, LabCorp Diagnostics
|
|
+747
|
$169.66
|
+$126.74K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
+3K
|
$169.66
|
+$501.51K
|
|
SEC
|
Ratliff John D
|
CEO, Covance Drug Development
|
|
+1.3K
|
$169.66
|
+$221.07K
|
|
SEC
|
Uthgenannt Lisa J
|
Chief Human Resources Officer
|
|
+197
|
$169.66
|
+$33.42K
|
|
SEC
|
Gilliland Dwight Gary
|
N/A
|
|
-971
|
$153.52
|
-$149.07K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-1.7K
|
$123.13
|
-$203.16K
|
|
SEC
|
Gary M. Huff
|
CEO, LabCorp Diagnostics
|
|
+102
|
$157.61
|
+$16.08K
|
|
SEC
|
Dodson Edward T
|
Principal Accounting Officer
|
|
-2.9K
|
$160.13
|
-$459.73K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
-6K
|
$159.46
|
-$951.66K
|
|
SEC
|
Uthgenannt Lisa J
|
Chief Human Resources Officer
|
|
-5K
|
$160.00
|
-$800.00K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+2.1K
|
$140.77
|
+$299.00K
|
|
SEC
|
BERBERIAN LANCE
|
SVP, Chief Information Officer
|
|
-3.6K
|
$139.84
|
-$505.24K
|
|
SEC
|
BERBERIAN LANCE
|
SVP, Chief Information Officer
|
|
+3.6K
|
$45.46
|
+$164.25K
|
|
SEC
|
Dodson Edward T
|
Principal Accounting Officer
|
|
+3.9K
|
$42.49
|
+$165.92K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
+4.6K
|
$41.88
|
+$190.89K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+11K
|
$46.15
|
+$496.44K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
+54K
|
$46.14
|
+$2.47M
|
|
SEC
|
BERBERIAN LANCE
|
SVP, Chief Information Officer
|
|
+268
|
$144.24
|
+$38.66K
|
|
SEC
|
Dodson Edward T
|
Principal Accounting Officer
|
|
+251
|
$144.24
|
+$36.20K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
+310
|
$144.24
|
+$44.71K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+853
|
$144.24
|
+$123.04K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
+3.2K
|
$144.24
|
+$459.69K
|
|
SEC
|
Uthgenannt Lisa J
|
Chief Human Resources Officer
|
|
+4.6K
|
$144.24
|
+$658.17K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
-2.3K
|
$142.47
|
-$327.68K
|
|
SEC
|
MITTELSTAEDT ROBERT E JR
|
N/A
|
|
-5.3K
|
$142.69
|
-$756.26K
|
|
SEC
|
ANDERSON KERRII B
|
N/A
|
|
-2K
|
$140.00
|
-$278.88K
|
|
SEC
|
BERBERIAN LANCE
|
SVP, Chief Information Officer
|
|
+2K
|
$134.93
|
+$267.43K
|
|
SEC
|
Dodson Edward T
|
Principal Accounting Officer
|
|
+368
|
$134.93
|
+$49.65K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
+428
|
$134.93
|
+$57.75K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+1.1K
|
$134.93
|
+$151.39K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
+4.4K
|
$134.93
|
+$590.45K
|
|
SEC
|
BELINGARD JEAN-LUC
|
N/A
|
|
+1.4K
|
$133.83
|
+$187.90K
|
|
SEC
|
BERBERIAN LANCE
|
SVP, Chief Information Officer
|
|
+2.3K
|
$133.83
|
+$311.15K
|
|
SEC
|
Dodson Edward T
|
Principal Accounting Officer
|
|
+312
|
$133.83
|
+$41.75K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
+332
|
$133.83
|
+$44.43K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
+3.3K
|
$133.83
|
+$437.09K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
+5K
|
$133.83
|
+$675.44K
|
|
SEC
|
Ratliff John D
|
CEO, Covance Drug Development
|
|
+4.1K
|
$133.83
|
+$546.96K
|
|
SEC
|
Uthgenannt Lisa J
|
Chief Human Resources Officer
|
|
+359
|
$133.83
|
+$48.04K
|
|
SEC
|
Uthgenannt Lisa J
|
Chief Human Resources Officer
|
|
-1.2K
|
$140.00
|
-$164.78K
|
|
SEC
|
EISENBERG GLENN A
|
Chief Financial Officer, EVP
|
|
-8K
|
$140.10
|
-$1.12M
|
|
SEC
|
MITTELSTAEDT ROBERT E JR
|
N/A
|
|
-992
|
$140.15
|
-$139.03K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-196K
|
$128.00
|
-$25.14M
|
|
SEC
|
Uthgenannt Lisa J
|
Chief Human Resources Officer
|
|
-3.7K
|
$125.17
|
-$468.14K
|
|
SEC
|
Dodson Edward T
|
Principal Accounting Officer
|
|
-9.4K
|
$126.42
|
-$1.19M
|
|
SEC
|
Boyle James T. Jr.
|
EVP,CEO of LabCorp Diagnostics
|
|
-18K
|
$116.81
|
-$2.12M
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
-4.2K
|
$116.85
|
-$492.99K
|
|
SEC
|
Boyle James T. Jr.
|
EVP,CEO of LabCorp Diagnostics
|
|
-1.5K
|
$115.32
|
-$177.94K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
-309
|
$115.32
|
-$35.63K
|
|
SEC
|
BELINGARD JEAN-LUC
|
N/A
|
|
-1.3K
|
$109.74
|
-$142.22K
|
|
SEC
|
Boyle James T. Jr.
|
EVP,CEO of LabCorp Diagnostics
|
|
-4.1K
|
$103.02
|
-$417.75K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
-370
|
$103.02
|
-$38.12K
|
|
SEC
|
Boyle James T. Jr.
|
EVP,CEO of LabCorp Diagnostics
|
|
-2.7K
|
$101.67
|
-$275.73K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
-405
|
$101.67
|
-$41.18K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
-1.2K
|
$119.05
|
-$144.65K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
-1K
|
$123.31
|
-$124.54K
|
|
SEC
|
Williams R Sanders
|
N/A
|
|
-1.9K
|
$124.30
|
-$229.96K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-50K
|
$127.93
|
-$6.40M
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-50K
|
$121.78
|
-$6.09M
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-50K
|
$118.58
|
-$5.93M
|
|
SEC
|
MITTELSTAEDT ROBERT E JR
|
N/A
|
|
-1.3K
|
$119.02
|
-$154.25K
|
|
SEC
|
Williams R Sanders
|
N/A
|
|
-965
|
$118.05
|
-$113.92K
|
|
SEC
|
BELINGARD JEAN-LUC
|
N/A
|
|
-1.5K
|
$123.10
|
-$189.82K
|
|
SEC
|
Boyle James T. Jr.
|
EVP,CEO of LabCorp Diagnostics
|
|
-1.4K
|
$126.56
|
-$176.42K
|
|
SEC
|
Brecher Mark E
|
CMO, LabCorp Diagnostics
|
|
-21K
|
$126.98
|
-$2.62M
|
|
SEC
|
Boyle James T. Jr.
|
EVP, Chief Operating Officer
|
|
-1.2K
|
$123.70
|
-$153.02K
|
|
SEC
|
Williams R Sanders
|
N/A
|
|
-2.3K
|
$123.96
|
-$281.02K
|
|
SEC
|
HERRING JOSEPH L
|
CEO of Covance Drug Division
|
|
-37K
|
$121.64
|
-$4.49M
|
|
SEC
|
Boyle James T. Jr.
|
EVP, Chief Operating Officer
|
|
-6.6K
|
$116.68
|
-$769.74K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-65K
|
$104.71
|
-$6.83M
|
|
SEC
|
Williams R Sanders
|
N/A
|
|
-2K
|
$107.95
|
-$215.90K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-65K
|
$106.10
|
-$6.92M
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-65K
|
$105.55
|
-$6.89M
|
|
SEC
|
Boyle James T. Jr.
|
EVP, Chief Operating Officer
|
|
-39K
|
$103.00
|
-$3.98M
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
-10K
|
$104.37
|
-$1.04M
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-47K
|
$104.23
|
-$4.94M
|
|
SEC
|
Brecher Mark E
|
Chief Medical Officer
|
|
-2.6K
|
$102.31
|
-$266.01K
|
|
SEC
|
WEIKEL M KEITH
|
N/A
|
|
-2K
|
$98.28
|
-$194.99K
|
|
SEC
|
BELINGARD JEAN-LUC
|
N/A
|
|
-2K
|
$98.68
|
-$195.78K
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-2.5K
|
$98.39
|
-$245.68K
|
|
SEC
|
LANE WENDY E
|
N/A
|
|
-390
|
$98.97
|
-$38.60K
|
|
SEC
|
MITTELSTAEDT ROBERT E JR
|
N/A
|
|
-3.5K
|
$98.39
|
-$346.92K
|
|
SEC
|
Boyle James T. Jr.
|
EVP, Chief Operating Officer
|
|
-2.5K
|
$98.36
|
-$247.97K
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-24K
|
$94.40
|
-$2.25M
|
|
SEC
|
Boyle James T. Jr.
|
EVP, Chief Operating Officer
|
|
-1.6K
|
$93.06
|
-$147.22K
|
|
SEC
|
Boyle James T. Jr.
|
EVP, Chief Operating Officer
|
|
-4.1K
|
$90.29
|
-$372.27K
|
|
SEC
|
Boyle James T. Jr.
|
EVP, Chief Operating Officer
|
|
-1.2K
|
$91.15
|
-$109.74K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-24K
|
$90.15
|
-$2.18M
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-25K
|
$90.79
|
-$2.27M
|
|
SEC
|
Brecher Mark E
|
Chief Medical Officer
|
|
-400
|
$105.62
|
-$42.25K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-25K
|
$106.01
|
-$2.65M
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
-10K
|
$105.84
|
-$1.06M
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-25K
|
$100.91
|
-$2.52M
|
|
SEC
|
Boyle James T. Jr.
|
EVP, Chief Operating Officer
|
|
-24K
|
$102.00
|
-$2.49M
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-25K
|
$99.06
|
-$2.48M
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-25K
|
$96.60
|
-$2.42M
|
|
SEC
|
MITTELSTAEDT ROBERT E JR
|
N/A
|
|
-7.4K
|
$96.86
|
-$719.57K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-25K
|
$97.72
|
-$2.44M
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-25K
|
$98.66
|
-$2.47M
|
|
SEC
|
Boyle James T. Jr.
|
EVP, Chief Operating Officer
|
|
-63K
|
$99.63
|
-$6.29M
|
|
SEC
|
Brecher Mark E
|
Chief Medical Officer
|
|
-17K
|
$100.92
|
-$1.71M
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-127K
|
$100.00
|
-$12.72M
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
-10K
|
$98.47
|
-$984.70K
|
|
SEC
|
Boyle James T. Jr.
|
EVP, Chief Operating Officer
|
|
-69K
|
$93.82
|
-$6.46M
|
|
SEC
|
BELINGARD JEAN-LUC
|
N/A
|
|
-2.5K
|
$92.88
|
-$235.54K
|
|
SEC
|
WEIKEL M KEITH
|
N/A
|
|
-2K
|
$92.91
|
-$190.09K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
-1.5K
|
$93.84
|
-$140.76K
|
|
SEC
|
Williams R Sanders
|
N/A
|
|
-1.9K
|
$93.77
|
-$173.47K
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-4.9K
|
$89.96
|
-$445.21K
|
|
SEC
|
MAC MAHON THOMAS P
|
N/A
|
|
-35K
|
$89.74
|
-$3.14M
|
|
SEC
|
MITTELSTAEDT ROBERT E JR
|
N/A
|
|
-2.5K
|
$88.61
|
-$224.71K
|
|
SEC
|
Brecher Mark E
|
Chief Medical Officer
|
|
-20K
|
$95.00
|
-$1.93M
|
|
SEC
|
Fonseca Lidia
|
Chief Information Officer
|
|
-18K
|
$95.00
|
-$1.73M
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-85K
|
$92.11
|
-$7.81M
|
|
SEC
|
Fonseca Lidia
|
Chief Information Officer
|
|
-1.7K
|
$90.00
|
-$151.83K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
-2.7K
|
$83.83
|
-$224.50K
|
|
SEC
|
LANE WENDY E
|
N/A
|
|
-510
|
$85.98
|
-$43.85K
|
|
SEC
|
LANE WENDY E
|
N/A
|
|
-800
|
$86.46
|
-$69.17K
|
|
SEC
|
BELINGARD JEAN-LUC
|
N/A
|
|
-1.4K
|
$88.11
|
-$119.21K
|
|
SEC
|
Walton Andrew Scott
|
EVP
|
|
-4K
|
$91.82
|
-$367.28K
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-16K
|
$91.39
|
-$1.51M
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-77K
|
$89.68
|
-$6.87M
|
|
SEC
|
MAC MAHON THOMAS P
|
N/A
|
|
-60K
|
$89.98
|
-$5.40M
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-20K
|
$92.00
|
-$1.84M
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-20K
|
$88.00
|
-$1.76M
|
|
SEC
|
MITTELSTAEDT ROBERT E JR
|
N/A
|
|
-817
|
$79.96
|
-$65.33K
|
|
SEC
|
Williams R Sanders
|
N/A
|
|
-6.3K
|
$100.73
|
-$633.79K
|
|
SEC
|
EBERTS F SAMUEL III
|
Chief Legal Officer, Secretary
|
|
-15K
|
$99.04
|
-$1.51M
|
|
SEC
|
BELINGARD JEAN-LUC
|
N/A
|
|
-1.9K
|
$98.79
|
-$187.31K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-7.3K
|
$95.86
|
-$695.37K
|
|
SEC
|
Brecher Mark E
|
Chief Medical Officer
|
|
-1.3K
|
$98.00
|
-$124.56K
|
|
SEC
|
MAC MAHON THOMAS P
|
N/A
|
|
-155K
|
$95.52
|
-$14.81M
|
|
SEC
|
Walton Andrew Scott
|
EVP
|
|
-1.5K
|
$95.00
|
-$145.83K
|
|
SEC
|
Walton Andrew Scott
|
EVP
|
|
-1.5K
|
$92.69
|
-$142.37K
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-5.4K
|
$91.21
|
-$489.89K
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-1.2K
|
$87.45
|
-$105.64K
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-1.8K
|
$87.18
|
-$160.93K
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-32K
|
$88.18
|
-$2.81M
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-30K
|
$87.95
|
-$2.67M
|
|
SEC
|
MAC MAHON THOMAS P
|
N/A
|
|
-155K
|
$85.00
|
-$13.18M
|
|
SEC
|
Walton Andrew Scott
|
EVP
|
|
-881
|
$81.00
|
-$71.36K
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-30K
|
$80.00
|
-$2.40M
|
|
SEC
|
Walton Andrew Scott
|
EVP
|
|
-5K
|
$79.50
|
-$397.50K
|
|
SEC
|
Walton Andrew Scott
|
EVP
|
|
-881
|
$79.00
|
-$69.60K
|
|
SEC
|
MITTELSTAEDT ROBERT E JR
|
N/A
|
|
-1.9K
|
$74.32
|
-$140.91K
|
|
SEC
|
Conrad Andrew J
|
EVP, Chief Scientific Officer
|
|
+6.1K
|
$74.32
|
+$453.35K
|
|
SEC
|
Walton Andrew Scott
|
EVP
|
|
-924
|
$76.00
|
-$70.22K
|
|
SEC
|
LANE WENDY E
|
N/A
|
|
-617
|
$75.77
|
-$46.75K
|
|
SEC
|
BELINGARD JEAN-LUC
|
N/A
|
|
-4.1K
|
$78.20
|
-$321.87K
|
|
SEC
|
LANE WENDY E
|
N/A
|
|
-648
|
$79.74
|
-$51.67K
|
|
SEC
|
LANE WENDY E
|
N/A
|
|
-4.7K
|
$79.92
|
-$372.03K
|
|
SEC
|
Brecher Mark E
|
Chief Medical Officer
|
|
-173
|
$78.00
|
-$13.49K
|
|
SEC
|
Fonseca Lidia
|
Chief Information Officer
|
|
-132
|
$78.00
|
-$10.30K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-11K
|
$79.88
|
-$908.24K
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-6.7K
|
$76.09
|
-$508.59K
|
|
SEC
|
MAC MAHON THOMAS P
|
N/A
|
|
-68K
|
$77.17
|
-$5.25M
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-3.5K
|
$77.00
|
-$269.50K
|
|
SEC
|
Fonseca Lidia
|
Chief Information Officer
|
|
-163
|
$76.00
|
-$12.39K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-34K
|
$74.10
|
-$2.51M
|
|
SEC
|
MAC MAHON THOMAS P
|
N/A
|
|
-36K
|
$77.00
|
-$2.75M
|
|
SEC
|
MAC MAHON THOMAS P
|
N/A
|
|
-15K
|
$77.00
|
-$1.12M
|
|
SEC
|
Conrad Andrew J
|
EVP, Chief Scientific Officer
|
|
-10K
|
$74.00
|
-$740.00K
|
|
SEC
|
MITTELSTAEDT ROBERT E JR
|
N/A
|
|
-4.1K
|
$74.60
|
-$307.05K
|
|
SEC
|
LANE WENDY E
|
N/A
|
|
-4.1K
|
$68.70
|
-$282.77K
|
|
SEC
|
LANE WENDY E
|
N/A
|
|
-2.6K
|
$68.78
|
-$179.10K
|
|
SEC
|
HARDISON DON M
|
EVP, COO
|
|
-1.4K
|
$61.73
|
-$86.85K
|
|
SEC
|
Walton Andrew Scott
|
EVP
|
|
-3.5K
|
$63.88
|
-$223.58K
|
|
SEC
|
SMITH BRADFORD T
|
N/A
|
|
-6.1K
|
$61.67
|
-$374.09K
|
|
SEC
|
MAC MAHON THOMAS P
|
N/A
|
|
-276K
|
$61.70
|
-$17.04M
|
|
SEC
|
LANE WENDY E
|
N/A
|
|
+400
|
$60.96
|
+$24.38K
|
|
SEC
|
MAC MAHON THOMAS P
|
N/A
|
|
-238K
|
$66.99
|
-$15.93M
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-12K
|
$75.07
|
-$918.56K
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-23K
|
$73.16
|
-$1.66M
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-24K
|
$73.48
|
-$1.80M
|
|
SEC
|
MAC MAHON THOMAS P
|
N/A
|
|
-38K
|
$73.54
|
-$2.78M
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-32K
|
$73.55
|
-$2.39M
|
|
SEC
|
Walton Andrew Scott
|
EVP & CIO
|
|
-1.8K
|
$78.22
|
-$144.39K
|
|
SEC
|
Miller Benjamin R
|
EVP, Sales & Marketing
|
|
-5.1K
|
$78.94
|
-$403.94K
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-959
|
$77.40
|
-$74.23K
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-1.6K
|
$77.11
|
-$124.22K
|
|
SEC
|
MAC MAHON THOMAS P
|
N/A
|
|
-171K
|
$76.73
|
-$13.12M
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-32K
|
$76.87
|
-$2.46M
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-1.9K
|
$79.22
|
-$149.81K
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-1.6K
|
$79.23
|
-$127.64K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-2.4K
|
$79.24
|
-$190.02K
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-3K
|
$79.87
|
-$237.69K
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-1.6K
|
$79.69
|
-$128.38K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-3.1K
|
$79.68
|
-$244.54K
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-2.4K
|
$80.09
|
-$194.78K
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-8.2K
|
$79.81
|
-$652.53K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-16K
|
$79.36
|
-$1.24M
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-50K
|
$80.00
|
-$4.03M
|
|
SEC
|
Miller Benjamin R
|
EVP, Sales & Marketing
|
|
-12K
|
$80.00
|
-$960.00K
|
|
SEC
|
Miller Benjamin R
|
EVP, Sales & Marketing
|
|
-2.4K
|
$71.65
|
-$170.96K
|
|
SEC
|
MAC MAHON THOMAS P
|
N/A
|
|
-200K
|
$68.04
|
-$13.61M
|
|
SEC
|
Cook Woodrow L
|
EVP, Eastern Operations
|
|
-18K
|
$69.12
|
-$1.21M
|
|
SEC
|
Cook Woodrow L
|
EVP, Eastern Operations
|
|
-18K
|
$68.29
|
-$1.20M
|
|
SEC
|
Miller Benjamin R
|
EVP, Sales & Marketing
|
|
-4K
|
$76.00
|
-$304.00K
|
|
SEC
|
MAC MAHON THOMAS P
|
N/A
|
|
-200K
|
$72.60
|
-$14.52M
|
|
SEC
|
HAAS WILLIAM
|
EVP, Esoterix Business
|
|
-29K
|
$80.00
|
-$2.32M
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-15K
|
$80.01
|
-$1.18M
|
|
SEC
|
HAAS WILLIAM
|
EVP, Esoterix Business
|
|
-1K
|
$80.00
|
-$80.00K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-300
|
$80.00
|
-$24.00K
|
|
SEC
|
Miller Benjamin R
|
EVP, Sales & Marketing
|
|
-224
|
$79.10
|
-$17.72K
|
|
SEC
|
Miller Benjamin R
|
EVP, Sales & Marketing
|
|
-224
|
$79.35
|
-$17.77K
|
|
SEC
|
MITTELSTAEDT ROBERT E JR
|
N/A
|
|
-3.1K
|
$78.97
|
-$246.07K
|
|
SEC
|
HAAS WILLIAM
|
EVP, Esoterix Business
|
|
-10K
|
$78.35
|
-$816.49K
|
|
SEC
|
Miller Benjamin R
|
EVP, Sales & Marketing
|
|
-4.3K
|
$78.80
|
-$338.84K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-19K
|
$78.64
|
-$1.53M
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-6.1K
|
$77.00
|
-$471.63K
|
|
SEC
|
KING DAVID P
|
President & CEO
|
|
-4.8K
|
$77.30
|
-$372.35K
|
|
SEC
|
MAC MAHON THOMAS P
|
N/A
|
|
-85K
|
$72.53
|
-$6.15M
|
|
SEC
|
Cook Woodrow L
|
EVP, Eastern Operations
|
|
-479
|
$72.75
|
-$34.85K
|
|
SEC
|
Miller Benjamin R
|
EVP, Sales & Marketing
|
|
-449
|
$73.50
|
-$33.00K
|
|
SEC
|
Cook Woodrow L
|
EVP, Eastern Operations
|
|
-718
|
$80.09
|
-$57.50K
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-2.2K
|
$80.37
|
-$178.58K
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-15K
|
$80.00
|
-$1.20M
|
|
SEC
|
Miller Benjamin R
|
EVP, Sales & Marketing
|
|
-4.3K
|
$80.22
|
-$344.95K
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-6.7K
|
$80.01
|
-$533.35K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-35K
|
$80.65
|
-$2.82M
|
|
SEC
|
Cook Woodrow L
|
EVP, Eastern Operations
|
|
-6K
|
$78.00
|
-$468.00K
|
|
SEC
|
WALLACE ANDREW G
|
N/A
|
|
-4K
|
$78.00
|
-$310.75K
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-1.6K
|
$73.14
|
-$113.81K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-4.3K
|
$73.14
|
-$311.14K
|
|
SEC
|
Cook Woodrow L
|
EVP, Eastern Operations
|
|
-7K
|
$73.30
|
-$513.10K
|
|
SEC
|
WALLACE ANDREW G
|
N/A
|
|
-1.3K
|
$73.94
|
-$99.45K
|
|
SEC
|
MAC MAHON THOMAS P
|
CEO and Chairman of the Board
|
|
-77K
|
$67.15
|
-$5.16M
|
|
SEC
|
Miller Benjamin R
|
EVP, Sales
|
|
-14K
|
$68.50
|
-$959.00K
|
|
SEC
|
WALLACE ANDREW G
|
N/A
|
|
-2.2K
|
$68.21
|
-$152.86K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-15K
|
$65.00
|
-$975.00K
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-10K
|
$63.00
|
-$630.00K
|
|
SEC
|
WALLACE ANDREW G
|
N/A
|
|
-2.2K
|
$62.04
|
-$139.09K
|
|
SEC
|
HAAS WILLIAM
|
EVP, Sales & Marketing
|
|
-6.2K
|
$59.60
|
-$368.03K
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-50K
|
$60.01
|
-$2.98M
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-17K
|
$60.01
|
-$1.04M
|
|
SEC
|
KING DAVID P
|
EVP & Chief Operating Officer
|
|
-12K
|
$58.60
|
-$728.57K
|
|
SEC
|
MAC MAHON THOMAS P
|
CEO and Chairman of the Board
|
|
-78K
|
$56.98
|
-$4.44M
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-681
|
$60.00
|
-$40.86K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-237
|
$60.00
|
-$14.22K
|
|
SEC
|
Hayes William B
|
Chief Financial Officer, EVP
|
|
-1.8K
|
$59.33
|
-$106.79K
|
|
SEC
|
NOVAK RICHARD L
|
EVP, Strategic Planning
|
|
-2.5K
|
$57.80
|
-$146.58K
|
|
SEC
|
Hayes William B
|
Sr. Vice President
|
|
-6.1K
|
$58.04
|
-$353.41K
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-1.6K
|
$57.96
|
-$93.37K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-2.1K
|
$57.96
|
-$119.51K
|
|
SEC
|
Hayes William B
|
Sr. Vice President
|
|
-12K
|
$58.30
|
-$672.37K
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-17K
|
$58.27
|
-$978.94K
|
|
SEC
|
NOVAK RICHARD L
|
EVP & Strategic Planning
|
|
-90K
|
$58.27
|
-$5.26M
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-35K
|
$57.98
|
-$2.03M
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-17K
|
$58.05
|
-$975.24K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-35K
|
$58.04
|
-$2.03M
|
|
SEC
|
KING DAVID P
|
EVP & Chief Operating Officer
|
|
-8.4K
|
$57.66
|
-$484.34K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-35K
|
$57.63
|
-$2.02M
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-37K
|
$55.00
|
-$2.04M
|
|
SEC
|
NOVAK RICHARD L
|
EVP & Strategic Planning
|
|
-141K
|
$54.96
|
-$7.76M
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-67K
|
$55.00
|
-$3.69M
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-9.5K
|
$54.75
|
-$517.72K
|
|
SEC
|
NOVAK RICHARD L
|
EVP & Strategic Planning
|
|
-15K
|
$55.00
|
-$836.50K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-19K
|
$54.73
|
-$1.02M
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-4.4K
|
$55.00
|
-$241.18K
|
|
SEC
|
NOVAK RICHARD L
|
EVP & Strategic Planning
|
|
-15K
|
$55.00
|
-$834.13K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-7.9K
|
$55.00
|
-$437.09K
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-6.4K
|
$55.00
|
-$350.41K
|
|
SEC
|
NOVAK RICHARD L
|
EVP & Strategic Planning
|
|
-22K
|
$55.00
|
-$1.21M
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-12K
|
$55.00
|
-$635.09K
|
|
SEC
|
KING DAVID P
|
EVP & Chief Operating Officer
|
|
-2K
|
$55.00
|
-$109.51K
|
|
SEC
|
KING DAVID P
|
EVP & Chief Operating Officer
|
|
-11K
|
$52.80
|
-$554.40K
|
|
SEC
|
Miller Benjamin R
|
EVP, Oncology Products & Serv
|
|
-3.1K
|
$48.29
|
-$149.70K
|
|
SEC
|
MAC MAHON THOMAS P
|
CEO and Chairman of the Board
|
|
-60K
|
$48.22
|
-$2.89M
|
|
SEC
|
HAAS WILLIAM
|
EVP, Sales & Marketing
|
|
-61K
|
$51.00
|
-$3.10M
|
|
SEC
|
MAC MAHON THOMAS P
|
CEO and Chairman of the Board
|
|
-68K
|
$49.53
|
-$3.37M
|
|
SEC
|
KING DAVID P
|
EVP, Strategic Planning
|
|
-3.3K
|
$49.60
|
-$162.04K
|
|
SEC
|
Watson Craig M
|
N/A
|
|
-43
|
$50.50
|
-$2.17K
|
|
SEC
|
ELINGBURG WESLEY R
|
EVP & Chief Financial Officer
|
|
-18K
|
$50.00
|
-$875.00K
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-17K
|
$50.15
|
-$842.52K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-18K
|
$50.00
|
-$875.00K
|
|
SEC
|
Hayes William B
|
Sr. Vice President
|
|
-34K
|
$48.91
|
-$1.67M
|
|
SEC
|
Watson Craig M
|
N/A
|
|
-130
|
$48.33
|
-$6.28K
|
|
SEC
|
MAC MAHON THOMAS P
|
CEO and Chairman of the Board
|
|
-196K
|
$48.37
|
-$9.49M
|
|
SEC
|
ELINGBURG WESLEY R
|
EVP & Chief Financial Officer
|
|
-27K
|
$46.15
|
-$1.25M
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-14K
|
$45.80
|
-$661.17K
|
|
SEC
|
NOVAK RICHARD L
|
EVP & Chief Operating Officer
|
|
-35K
|
$45.80
|
-$1.60M
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-27K
|
$46.15
|
-$1.25M
|
|
SEC
|
ELINGBURG WESLEY R
|
EVP & Chief Financial Officer
|
|
-35K
|
$48.39
|
-$1.69M
|
|
SEC
|
NOVAK RICHARD L
|
EVP & Chief Operating Officer
|
|
-45K
|
$48.39
|
-$2.18M
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-35K
|
$48.39
|
-$1.69M
|
|
SEC
|
ELINGBURG WESLEY R
|
EVP & Chief Financial Officer
|
|
-27K
|
$50.00
|
-$1.37M
|
|
SEC
|
NOVAK RICHARD L
|
EVP & Chief Operating Officer
|
|
-59K
|
$50.00
|
-$2.96M
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-35K
|
$50.00
|
-$1.73M
|
|
SEC
|
ELINGBURG WESLEY R
|
EVP & Chief Financial Officer
|
|
-6K
|
$50.00
|
-$299.85K
|
|
SEC
|
NOVAK RICHARD L
|
EVP & Chief Operating Officer
|
|
-6K
|
$50.00
|
-$298.35K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-7.5K
|
$50.00
|
-$376.80K
|
|
SEC
|
ELINGBURG WESLEY R
|
EVP & Chief Financial Officer
|
|
-11K
|
$50.00
|
-$552.05K
|
|
SEC
|
NOVAK RICHARD L
|
EVP & Chief Operating Officer
|
|
-11K
|
$50.00
|
-$549.30K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-14K
|
$50.00
|
-$693.65K
|
|
SEC
|
ELINGBURG WESLEY R
|
EVP & Chief Financial Officer
|
|
-8.1K
|
$50.00
|
-$402.85K
|
|
SEC
|
NOVAK RICHARD L
|
EVP & Chief Operating Officer
|
|
-8K
|
$50.00
|
-$400.90K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-10K
|
$50.00
|
-$506.25K
|
|
SEC
|
ELINGBURG WESLEY R
|
EVP & Chief Financial Officer
|
|
-11K
|
$50.00
|
-$566.25K
|
|
SEC
|
KING DAVID P
|
EVP, Strategic Planning
|
|
-10K
|
$50.00
|
-$500.00K
|
|
SEC
|
NOVAK RICHARD L
|
EVP & Chief Operating Officer
|
|
-11K
|
$50.00
|
-$563.50K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-14K
|
$50.00
|
-$711.50K
|
|
SEC
|
Watson Craig M
|
N/A
|
|
-295
|
$40.92
|
-$12.07K
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-54K
|
$48.00
|
-$2.61M
|
|
SEC
|
ELINGBURG WESLEY R
|
EVP & Chief Financial Officer
|
|
-16K
|
$47.50
|
-$738.86K
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP & Chief Medical Officer
|
|
-3K
|
$47.50
|
-$142.50K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-16K
|
$47.50
|
-$738.86K
|
|
SEC
|
HAAS WILLIAM
|
EVP, Sales & Marketing
|
|
-4.9K
|
$47.10
|
-$229.24K
|
|
SEC
|
ELINGBURG WESLEY R
|
EVP & Chief Financial Officer
|
|
-78K
|
$45.15
|
-$3.51M
|
|
SEC
|
KING DAVID P
|
EVP, Strategic Planning
|
|
-5K
|
$45.00
|
-$225.00K
|
|
SEC
|
NOVAK RICHARD L
|
EVP & Chief Operating Officer
|
|
-194K
|
$45.15
|
-$8.78M
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chf Legal Offcr,Secretary
|
|
-47K
|
$45.15
|
-$2.11M
|
|
SEC
|
MAC MAHON THOMAS P
|
Chairman of the Board, CEO
|
|
-34K
|
$39.69
|
-$1.36M
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP, Chief Scientific Officer
|
|
-12K
|
$42.00
|
-$504.00K
|
|
SEC
|
WALLACE ANDREW G
|
N/A
|
|
-5.1K
|
$39.92
|
-$201.80K
|
|
SEC
|
MITTELSTAEDT ROBERT E JR
|
N/A
|
|
-4K
|
$40.11
|
-$160.88K
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP, Chief Scientific Officer
|
|
-8.3K
|
$40.00
|
-$330.00K
|
|
SEC
|
MAC MAHON THOMAS P
|
Chairman of the Board, CEO
|
|
-27K
|
$40.00
|
-$1.08M
|
|
SEC
|
NOVAK RICHARD L
|
EVP, Chief Operating Officer
|
|
-22K
|
$40.00
|
-$886.52K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chief Legal Officer, Sec
|
|
-17K
|
$40.00
|
-$687.48K
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP, Chief Scientific Officer
|
|
-4.9K
|
$40.08
|
-$197.27K
|
|
SEC
|
MAC MAHON THOMAS P
|
Chairman, CEO, President
|
|
-24K
|
$40.08
|
-$965.93K
|
|
SEC
|
NOVAK RICHARD L
|
EVP, Chief Operating Officer
|
|
-13K
|
$40.08
|
-$530.02K
|
|
SEC
|
SMITH BRADFORD T
|
CEO, Chief Legal Officer, Sec
|
|
-10K
|
$40.08
|
-$410.98K
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP, Chief Scientific Officer
|
|
-3.6K
|
$40.02
|
-$145.19K
|
|
SEC
|
MAC MAHON THOMAS P
|
Chairman, CEO, President
|
|
-17K
|
$40.02
|
-$676.34K
|
|
SEC
|
NOVAK RICHARD L
|
EVP, COO
|
|
-9.7K
|
$40.02
|
-$390.07K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chief Legal Officer, Sec
|
|
-7.6K
|
$40.02
|
-$302.51K
|
|
SEC
|
MAC MAHON THOMAS P
|
Chairman, CEO, President
|
|
-198K
|
$39.15
|
-$7.77M
|
|
SEC
|
ELINGBURG WESLEY R
|
EVP, Chief Financial Officer
|
|
-14K
|
$37.52
|
-$534.81K
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP, Chief Scientific Officer
|
|
-6K
|
$37.72
|
-$226.89K
|
|
SEC
|
NOVAK RICHARD L
|
EVP & Chief Operating Officer
|
|
-18K
|
$37.52
|
-$678.21K
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chief Legal Officer, Sec
|
|
-14K
|
$37.52
|
-$534.81K
|
|
SEC
|
ELINGBURG WESLEY R
|
EVP, Chief Financial Officer
|
|
-37K
|
$37.93
|
-$1.39M
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP, Chief Scientific Officer
|
|
-15K
|
$37.93
|
-$587.19K
|
|
SEC
|
NOVAK RICHARD L
|
EVP, Chief Operating Officer
|
|
-47K
|
$37.93
|
-$1.76M
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chief Legal Officer, Sec
|
|
-37K
|
$37.93
|
-$1.39M
|
|
SEC
|
STARK STEVAN R
|
Executive Vice President
|
|
-21K
|
$37.50
|
-$806.10K
|
|
SEC
|
ELINGBURG WESLEY R
|
EVP, CFO, & Treasurer
|
|
-35K
|
$37.84
|
-$1.32M
|
|
SEC
|
HAAS WILLIAM
|
EVP, Sales & Marketing
|
|
-4.7K
|
$37.90
|
-$176.84K
|
|
SEC
|
STARK STEVAN R
|
Executive Vice President
|
|
-17K
|
$38.00
|
-$638.40K
|
|
SEC
|
STARK STEVAN R
|
Executive Vice President
|
|
-18K
|
$40.02
|
-$725.68K
|
|
SEC
|
ELINGBURG WESLEY R
|
EVP, CFO, and Treasurer
|
|
-10K
|
$42.50
|
-$425.00K
|
|
SEC
|
ELINGBURG WESLEY R
|
EVP, CFO, Treasurer
|
|
-9.2K
|
$40.00
|
-$368.00K
|
|
SEC
|
NOVAK RICHARD L
|
EVP, Chief Operating Officer
|
|
-52K
|
$40.00
|
-$2.09M
|
|
SEC
|
SMITH BRADFORD T
|
EVP, Chief Legal Officer, Sec
|
|
-18K
|
$40.00
|
-$736.00K
|
|
SEC
|
STARK STEVAN R
|
Executive Vice President
|
|
-18K
|
$40.00
|
-$725.32K
|
|
SEC
|
STARK STEVAN R
|
Executive Vice President
|
|
-23K
|
$38.00
|
-$866.40K
|
|
SEC
|
ELINGBURG WESLEY R
|
EVP, CFO, Treasurer
|
|
-9.2K
|
$37.50
|
-$345.00K
|
|
SEC
|
LAI GOLDMAN MYLA
|
EVP, Ch. Scien. Off, Med. Dir.
|
|
-15K
|
$35.24
|
-$521.55K
|
|
SEC
|
NOVAK RICHARD L
|
EVP, Chief Operating Officer
|
|
-20K
|
$35.24
|
-$704.80K
|
|
SEC
|
STARK STEVAN R
|
Executive Vice President
|
|
-13K
|
$31.28
|
-$416.65K
|
|